Literature DB >> 32333623

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements.

Ashley Woolmore1, Dirk Arnold2, Jean-Yves Blay3, Christian Buske4, Alfredo Carrato5, Winald Gerritsen6, Marc Peeters7, Jesus Garcia-Foncillas8, David Kerr9.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32333623      PMCID: PMC7543245          DOI: 10.1634/theoncologist.2019-0855

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159            Impact factor:   5.837


× No keyword cloud information.
  7 in total

Review 1.  ASCO's approach to a learning health care system in oncology.

Authors:  George W Sledge; Clifford A Hudis; Sandra M Swain; Peter M Yu; Joshua T Mann; Robert S Hauser; Allen S Lichter
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

2.  Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.

Authors:  Kala Visvanathan; Laura A Levit; Derek Raghavan; Clifford A Hudis; Sandra Wong; Amylou Dueck; Gary H Lyman
Journal:  J Clin Oncol       Date:  2017-03-30       Impact factor: 44.544

3.  Unwanted Variation in Cancer Care: It Is Time to Innovate and Change.

Authors:  James C Wade
Journal:  J Oncol Pract       Date:  2016-12-20       Impact factor: 3.840

Review 4.  Relevance of randomised controlled trials in oncology.

Authors:  Ian F Tannock; Eitan Amir; Christopher M Booth; Saroj Niraula; Alberto Ocana; Bostjan Seruga; Arnoud J Templeton; Francisco Vera-Badillo
Journal:  Lancet Oncol       Date:  2016-12       Impact factor: 41.316

Review 5.  The European Cancer Patient's Bill of Rights, update and implementation 2016.

Authors:  Mark Lawler; Ian Banks; Kate Law; Tit Albreht; Jean-Pierre Armand; Mariano Barbacid; Michèle Barzach; Jonas Bergh; David Cameron; Pierfranco Conte; Filippo de Braud; Aimery de Gramont; Francesco De Lorenzo; Volker Diehl; Sarper Diler; Sema Erdem; Jan Geissler; Jola Gore-Booth; Geoffrey Henning; Liselotte Højgaard; Denis Horgan; Jacek Jassem; Peter Johnson; Stein Kaasa; Peter Kapitein; Sakari Karjalainen; Joan Kelly; Anita Kienesberger; Carlo La Vecchia; Denis Lacombe; Tomas Lindahl; Bob Löwenberg; Lucio Luzzatto; Rebecca Malby; Ken Mastris; Françoise Meunier; Martin Murphy; Peter Naredi; Paul Nurse; Kathy Oliver; Jonathan Pearce; Jana Pelouchov; Martine Piccart; Bob Pinedo; Gilly Spurrier-Bernard; Richard Sullivan; Josep Tabernero; Cornelis Van de Velde; Bert van Herk; Peter Vedsted; Anita Waldmann; David Weller; Nils Wilking; Roger Wilson; Wendy Yared; Christoph Zielinski; Harald Zur Hausen; Thierry Le Chevalier; Patrick Johnston; Peter Selby
Journal:  ESMO Open       Date:  2017-01-06

Review 6.  Cancer Core Europe: A translational research infrastructure for a European mission on cancer.

Authors:  Alexander M M Eggermont; Giovanni Apolone; Michael Baumann; Carlos Caldas; Julio E Celis; Francesco de Lorenzo; Ingemar Ernberg; Ulrik Ringborg; John Rowell; Josep Tabernero; Emile Voest; Fabien Calvo
Journal:  Mol Oncol       Date:  2019-02-02       Impact factor: 6.603

7.  The Oncology Data Network (ODN): A Collaborative European Data-Sharing Platform to Inform Cancer Care.

Authors:  David Kerr; Dirk Arnold; Jean-Yves Blay; Christian Buske; Alfredo Carrato; Winald Gerritsen; Marc Peeters
Journal:  Oncologist       Date:  2019-09-05
  7 in total
  2 in total

1.  Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France.

Authors:  Pierre-Alexandre Squara; Vinh-Phuc Luu; David Pérol; Bruno Coudert; Valérie Machuron; Camille Bachot; Laurence Samelson; Virginie Florentin; Jean-Marc Pinguet; Béchir Ben Hadj Yahia
Journal:  PLoS One       Date:  2022-04-19       Impact factor: 3.752

Review 2.  Identifying options for oncology therapy regimen codification to improve standardization-combined results of an expert panel and a review.

Authors:  Robert Terkola; Christophe Bardin; Garbiñe Lizeaga Cundin; Nadine Zeinab; Mirjam Crul
Journal:  J Clin Pharm Ther       Date:  2021-03-09       Impact factor: 2.512

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.